Equities Analysts Set Expectations for SLNO FY2025 Earnings
Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Soleno Therapeutics in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska expects that the company ...
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $74.83 Average Price Target from Analysts
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have received a consensus recommendation of “Buy” from the seven research firms that are covering the company, MarketBeat.com ...
News Medical6d
Researchers launch startup to revolutionize targeted drug delivery using milk exosomes
Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in ...